Overview
Updated 14 Jul 2026
Kevin M. Brown, MD, is Senior Investigator, Head of the Kevin Brown Laboratory at National Cancer Institute, Division of Cancer Epidemiology and Genetics (DCEG), Laboratory of Translational Genomics. The public record shows 463 publications with 55,052 citations (h-index 87), centered on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Melanoma and MAPK Pathways, Systemic Sclerosis and Related Diseases. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 16 companies, 3 NIH-funded awards (1999–2017).
- Most recent indexed publication: 2026 · British journal of cancer
- Top research focus: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 16 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 28 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 217.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach
Sponsor: University of North Carolina, Chapel Hill
InvestigatorCompletedNCT02309099 - AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
Sponsor: Duke University
InvestigatorPhase 3TerminatedNCT00957242 - Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF
Sponsor: Duke University
InvestigatorPhase 3CompletedNCT00650091
Industry payments
Updated 14 Jul 2026
16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202520 payments$40,270openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim International GmbHProgram year20256 payments
- ABBVIE INC.Program year20251 payment
NIH funding
Updated 14 Jul 2026
3 NIH research awards on record, funded 1999–2017 per NIH RePORTER. The latest:
- Methods and Strategies for Chemical Synthesis
Trustees of Indiana University
FY2026$567,649R35GM131755 - Efficacy of targeting GAPM3 to block acute and chronic Toxoplasma gondii infections
University of Oklahoma Hlth Sciences Ctr
FY2026$463,290R01AI198553 - Methods and Strategies for Chemical Synthesis
Trustees of Indiana University
FY2025$569,676R35GM131755
Congress activity
Updated 14 Jul 2026
19 congress contributions (2011–2024) across AACR, ASCO, ASH, SABCS per OpenAlex. The most recent:
- Abstract LB226: Deciphering lung adenocarcinoma evolution and the role of LINE-1 retrotransposition
AACR Annual Meeting
AACR2024Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited worksby citation count (OpenAlex)
- 01
- 02Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis4,631 citations2014
- 03
- 04
- 05
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
9615 Medical Center Dr, Room SG/3126, Rockville, MD 20850
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dceg.cancer.gov ↗
Editorial & leadership rolesjournal and society appointments
- Member
International Melanoma Genetics Consortium (GenoMEL)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dceg.cancer.gov ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dceg.cancer.gov ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dceg.cancer.gov ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dceg.cancer.gov ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dceg.cancer.gov ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- X / Twitter
twitter.com/kbrowngenetics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →twitter.com ↗ - LinkedIn
linkedin.com/in/kevin-brown-19063543
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Dceg.cancer.gov
Twitter/X: @kbrowngenetics
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dceg.cancer.gov ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Stephen Chanock, MD
National Cancer Institute
- 2,221
- publications
- 170
- h-index
James Gulley, MD
National Cancer Institute
- 985
- publications
- 89
- h-index
- 28
- trials